Literature DB >> 22017934

The crux of maximum hyperemia: the last remaining barrier for routine use of fractional flow reserve.

Nico H J Pijls, Pim A L Tonino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22017934     DOI： 10.1016/j.jcin.2011.08.007

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN： 1936-8798            Impact factor:   11.195


× No keyword cloud information.
  11 in total

1.  Left ventricular end-diastolic pressure affects measurement of fractional flow reserve.

Authors:  Robert A Leonardi; Jacob C Townsend; Chetan A Patel; Bethany J Wolf; Thomas M Todoran; Valerian L Fernandes; Christopher D Nielsen; Daniel H Steinberg; Eric R Powers
Journal:  Cardiovasc Revasc Med       Date:  2013-07-23

2.  Integrating Physiology into the DNA of Coronary Revascularisation - A Historical Perspective, Contemporary Review and Blueprint for the Future of Coronary Physiology.

Authors:  Sen Sayan; Justin Davies
Journal:  Interv Cardiol       Date:  2015-05

3.  The FAME Trials: Impact on Clinical Decision Making.

Authors:  Guy R Heyndrickx; Gábor G Tóth
Journal:  Interv Cardiol       Date:  2016-10

4.  Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements.

Authors:  Daiki Kato; Hiroaki Takashima; Katsuhisa Waseda; Akiyoshi Kurita; Yasuo Kuroda; Takashi Kosaka; Yasushi Kuhara; Hirohiko Ando; Kazuyuki Maeda; Soichiro Kumagai; Shinichiro Sakurai; Akihiro Suzuki; Yukiko Toda; Atsushi Watanabe; Shigeko Sato; Masanobu Fujimoto; Tomofumi Mizuno; Tetsuya Amano
Journal:  Heart Vessels       Date:  2014-04-19       Impact factor: 2.037

Review 5.  Myocardial perfusion distribution and coronary arterial pressure and flow signals: clinical relevance in relation to multiscale modeling, a review.

Authors:  Froukje Nolte; Eoin R Hyde; Cristina Rolandi; Jack Lee; Pepijn van Horssen; Kal Asrress; Jeroen P H M van den Wijngaard; Andrew N Cookson; Tim van de Hoef; Radomir Chabiniok; Reza Razavi; Christian Michler; Gilion L T F Hautvast; Jan J Piek; Marcel Breeuwer; Maria Siebes; Eike Nagel; Nic P Smith; Jos A E Spaan
Journal:  Med Biol Eng Comput       Date:  2013-07-27       Impact factor: 2.602

6.  Assessment of increasing intravenous adenosine dose in fractional flow reserve.

Authors:  David Sparv; Matthias Götberg; Jan Harnek; Tobias Persson; Bjarne Madsen Hardig; David Erlinge
Journal:  BMC Cardiovasc Disord       Date:  2017-02-14       Impact factor: 2.298

7.  Diagnostic utility and safety of intracoronary nicorandil as a hyperemic agent for the measurement of fractional flow reserve.

Authors:  Rahul Chhabria; Nihar P Mehta; Nikesh Jain; Sham R Handa; Ashwin B Mehta
Journal:  Indian Heart J       Date:  2020-10-20

8.  Improvement in coronary haemodynamics after percutaneous coronary intervention: assessment using instantaneous wave-free ratio.

Authors:  Sukhjinder S Nijjer; Sayan Sen; Ricardo Petraco; Rajesh Sachdeva; Florim Cuculi; Javier Escaned; Christopher Broyd; Nicolas Foin; Nearchos Hadjiloizou; Rodney A Foale; Iqbal Malik; Ghada W Mikhail; Amarjit S Sethi; Mahmud Al-Bustami; Raffi R Kaprielian; Masood A Khan; Christopher S Baker; Michael F Bellamy; Alun D Hughes; Jamil Mayet; Rajesh K Kharbanda; Carlo Di Mario; Justin E Davies
Journal:  Heart       Date:  2013-09-18       Impact factor: 5.994

9.  The ongoing search for simplifying fractional flow reserve assessment: the role of contrast medium.

Authors:  Pio Cialdella; Domenico D'Amario; Antonio Maria Leone
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-08-19       Impact factor: 1.426

10.  Effect of High (200 μg/kg per Minute) Adenosine Dose Infusion on Fractional Flow Reserve Variability.

Authors:  Dimitrios Alexopoulos; Ioanna Xanthopoulou; Grigorios Tsigkas; Nikolaos Koutsogiannis; Paraskevi Salata; Stylianos Armylagos; Athanasios Moulias; Periklis Davlouros
Journal:  J Am Heart Assoc       Date:  2016-11-10       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.